Liao, Y., Guo, Z., Xia, X., Liu, Y., Huang, C., Jiang, L., . . . Huang, H. (2019). Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer. J Exp Clin Cancer Res.

Liao, Yuning, Zhiqiang Guo, Xiaohong Xia, Yuan Liu, Chuyi Huang, Lili Jiang, Xuejun Wang, Jinbao Liu, ja Hongbiao Huang. "Inhibition of EGFR Signaling With Spautin-1 Represents a Novel Therapeutics for Prostate Cancer." J Exp Clin Cancer Res 2019.

Liao, Yuning, et al. "Inhibition of EGFR Signaling With Spautin-1 Represents a Novel Therapeutics for Prostate Cancer." J Exp Clin Cancer Res 2019.